MAGLIANI, Valter
 Distribuzione geografica
Continente #
NA - Nord America 13.255
AS - Asia 11.740
EU - Europa 8.651
SA - Sud America 2.110
AF - Africa 705
Continente sconosciuto - Info sul continente non disponibili 185
OC - Oceania 5
Totale 36.651
Nazione #
US - Stati Uniti d'America 12.818
SG - Singapore 4.367
CN - Cina 3.577
VN - Vietnam 1.960
BR - Brasile 1.660
UA - Ucraina 1.493
DE - Germania 1.330
IE - Irlanda 1.310
FI - Finlandia 1.069
IT - Italia 1.013
SE - Svezia 893
HK - Hong Kong 839
ZA - Sudafrica 524
NL - Olanda 404
FR - Francia 403
CA - Canada 308
TR - Turchia 204
GB - Regno Unito 180
AR - Argentina 170
BD - Bangladesh 163
RU - Federazione Russa 154
AT - Austria 143
IN - India 116
EC - Ecuador 103
JP - Giappone 73
MX - Messico 73
IQ - Iraq 71
ID - Indonesia 54
ES - Italia 53
CO - Colombia 45
BE - Belgio 44
MA - Marocco 41
PL - Polonia 41
PY - Paraguay 37
PK - Pakistan 34
VE - Venezuela 34
KE - Kenya 32
PH - Filippine 31
EG - Egitto 27
CL - Cile 26
KR - Corea 25
UZ - Uzbekistan 24
JO - Giordania 22
TN - Tunisia 22
TW - Taiwan 22
TH - Thailandia 21
RO - Romania 20
SA - Arabia Saudita 20
EU - Europa 19
AZ - Azerbaigian 15
IL - Israele 15
KZ - Kazakistan 15
UY - Uruguay 15
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
LT - Lituania 13
NP - Nepal 13
ET - Etiopia 11
CI - Costa d'Avorio 10
CR - Costa Rica 10
BO - Bolivia 9
TT - Trinidad e Tobago 9
BG - Bulgaria 8
HU - Ungheria 8
OM - Oman 8
PE - Perù 8
CH - Svizzera 7
HN - Honduras 7
JM - Giamaica 7
AL - Albania 6
DZ - Algeria 6
IR - Iran 5
LB - Libano 5
NI - Nicaragua 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BY - Bielorussia 4
EE - Estonia 4
NG - Nigeria 4
PS - Palestinian Territory 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
AO - Angola 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HR - Croazia 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
XK - ???statistics.table.value.countryCode.XK??? 3
ZW - Zimbabwe 3
AM - Armenia 2
AU - Australia 2
BW - Botswana 2
Totale 36.439
Città #
Singapore 1.903
Jacksonville 1.542
Dublin 1.306
San Jose 1.296
Ashburn 1.083
Chandler 1.006
Beijing 961
Hong Kong 810
Dearborn 762
Council Bluffs 661
Ho Chi Minh City 627
Santa Clara 543
Boardman 503
Johannesburg 494
Nanjing 486
Hanoi 448
Dallas 414
Princeton 367
Lauterbourg 318
Ann Arbor 286
San Mateo 285
Munich 263
Toronto 220
Wilmington 208
New York 190
Parma 179
Helsinki 171
Kunming 171
Bremen 167
Shenyang 155
Hefei 154
Los Angeles 154
Izmir 152
Nanchang 139
Vienna 131
São Paulo 128
Shanghai 119
Hebei 118
Moscow 116
Des Moines 101
Jinan 95
Da Nang 83
Haiphong 81
Buffalo 73
Tianjin 72
Grafing 68
Jiaxing 63
Changsha 58
Guangzhou 58
Rio de Janeiro 58
Rome 55
Seattle 52
Woodbridge 51
Fortaleza 47
Norwalk 47
Turku 47
Brussels 42
Milan 42
Tokyo 42
Columbus 40
Brasília 38
Düsseldorf 37
Brooklyn 36
Frankfurt am Main 36
Biên Hòa 35
Fremont 35
Warsaw 34
Zhengzhou 34
Atlanta 33
Houston 32
Hải Dương 32
Marseille 32
Quito 32
Bắc Ninh 31
Hangzhou 31
Guayaquil 30
Orem 29
Baghdad 28
Nairobi 26
Can Tho 25
Chengdu 24
Salvador 24
Chennai 23
Montreal 23
Porto Alegre 23
Thái Bình 23
Belo Horizonte 22
Curitiba 22
The Dalles 22
Denver 21
Amman 20
Campinas 20
Chicago 20
Fuzhou 20
Phoenix 20
Tashkent 20
Boston 19
London 19
Nuremberg 19
Jakarta 18
Totale 21.379
Nome #
A transphyletic anti-infectious control strategy based on the killer phenomenon. 283
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 273
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 257
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 246
Capitolo 5. Differenziamento reale e differenziamento temporaneo. 235
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 231
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 216
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 207
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 204
A synthetic peptide as a novel anticryptococcal agent 197
Antibodies as a source of anti-infective peptides: an update 195
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 194
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 193
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 186
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 186
Screening of thiosemicarbazones as antimycotic drugs 183
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 180
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 177
Metabolic profiling of Candida albicans 177
Antifungal peptides within the antibodies 173
An engineered anti-idiotypic antibody-derived killer peptide (KP) early activates swine inflammatory monocytes, CD3+CD16+ natural killer T cells and CD4+CD8α+ double positive CD8β+ cytotoxic T lymphocytes associated with TNF-α and IFN-γ secretion 172
Antifungal activity of the C-terminal peptide from human serum albumin 170
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 169
Fungicidal activity of peptides encoded by immunoglobulin genes 168
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 168
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 167
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 164
Phenotypic modulation of porcine CD14+ monocytes, natural killer/natural killer T cells and CD8αβ+ T cell subsets by an antibody-derived killer peptide (KP) 162
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 161
Cap. 6. Differenziamento reale e differenziamento temporaneo. 160
L'identificazione dei batteri Gram negativi mediante il sistema ATB. 159
Metabolic Plasticity of Candida albicans in Response to Different Environmental Conditions 158
Antibody peptide based antifungal immunotherapy 156
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 156
Peptides from the inside of the antibodies are active against infectious agents and tumours 156
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 155
Anti-septic shock recombinant vaccine. 154
Natural and synthetic peptides with antifungal activity 154
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 153
Anticorpi immagini interne di tossine killer 152
Antibody-mediated protective immunity in fungal infections 151
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 151
Antibiobodies: antibiotic-like antiidiotypic antibodies. 146
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 145
Agenti virali di gastroenterite. 145
Antireceptor yeast killer toxin-like antibiobodies 143
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 143
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 143
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 143
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 142
Mode of action of a killer peptide against Toxoplasma gondii 140
Anticorpi antibiotici ricombinanti ad attività terapeutica fungicida. 139
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 138
Antibiobodies: antibiotic internal image antibodies 137
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 137
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 137
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 137
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 136
Metabolic profile of Candida albicans 134
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 134
Wickerhamomyces yeast killer toxins’ medical applications 134
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 133
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 133
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 132
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 130
Antibiotic antibodies 128
In vitro and in vivo anticandidal activity of killer peptide derivatives 127
Il sistema immunoenzimatico GM1 ELISA per la ricerca della tossina termolabile di E. coli. 126
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 126
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 125
Innate antimicrobial and antiviral activities of antibody peptides 125
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 125
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 124
Restriction of Influenza virus multiplication induced by PK peptide treatment 123
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 122
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 121
Antibodies as Crypts of Antiinfective and Antitumor Peptides 116
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 116
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 115
Any antibody fragment might exert antifungal activity 114
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 114
Antibiotic assay-based treatment of Helicobacter Pylori ( HP ) infection. 113
Candidacidal properties of peptides encoded by immunoglobulin genes 113
Human natural yeast killer toxin-like antibodies 112
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 112
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 112
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 112
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 111
Valutazione di un nuovo sistema automatizzato per l'identificazione e l'antibiogramma: L'identificazione rapida. Workshop: Recenti sviluppi e nuove prospettive dei metodi automatizzati per l'identificazione e l'antibiogramma. 111
Applicazioni della Biologia Molecolare in Micologia. 111
L'elettroferotipo come mezzo di indagine epidemiologica nelle gastroenteriti da rotavirus umani. 111
Valutazione di alcuni aspetti della nuova tecnologia VITEK2 effettuata presso gli Istituti di Microbiologia dell'Università di Parma e dell'Università Cattolica di Roma. Workshop: VITEK2: un mondo d'innovazione. 111
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 109
Protective antifungal yeast killer toxin-like antibodies 108
Caratterizzazione dell'amikacina-resistenza in Acinetobacter calcoaceticus varietà anitratus. 108
Ogni frammento anticorpale può esplicare attività antinfettiva ed antitumorale. 108
Spettro d'azione universale di mimotopi killer antifungini 106
L'automazione integrata nel Laboratorio di Batteriologia. 106
Therapeutic effect of an antibody-derived peptide in a Galleria mellonella model of systemic candidiasis 106
In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant Gram-positive cocci 105
Totale 14.922
Categoria #
all - tutte 129.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.611 0 4 17 62 52 86 226 300 66 109 157 532
2022/20234.451 594 381 220 287 474 513 28 230 1.571 18 91 44
2023/20241.528 92 163 83 40 136 427 41 72 25 79 126 244
2024/20255.546 48 415 404 285 412 536 157 193 946 602 380 1.168
2025/202612.377 1.015 1.300 1.546 1.603 1.696 601 1.601 438 1.495 700 259 123
2026/20271.153 564 589 0 0 0 0 0 0 0 0 0 0
Totale 36.651